KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 163 filers reported holding KARUNA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $169 | -22.1% | 1 | 0.0% | 0.00% | – |
| Q2 2023 | $217 | -60.2% | 1 | -66.7% | 0.00% | – |
| Q1 2023 | $545 | -7.6% | 3 | 0.0% | 0.00% | – |
| Q4 2022 | $590 | -41.0% | 3 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | – | 3 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 3 | -50.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 6 | +20.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 5 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 5 | -44.4% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 9 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | -50.0% | 9 | -40.0% | 0.00% | – |
| Q4 2020 | $2,000 | +100.0% | 15 | -6.2% | 0.00% | – |
| Q3 2020 | $1,000 | -50.0% | 16 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | +100.0% | 16 | +14.3% | 0.00% | – |
| Q1 2020 | $1,000 | – | 14 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,912,872 | $369,323,000 | 52.78% |
| Pivotal bioVenture Partners Investment Advisor LLC | 852,708 | $108,115,000 | 51.15% |
| Sofinnova Investments, Inc. | 1,953,077 | $247,631,000 | 18.79% |
| Nan Fung Group Holdings Ltd | 234,811 | $29,772,000 | 14.12% |
| Sands Capital Ventures, LLC | 267,895 | $33,966,000 | 7.10% |
| Logos Global Management LP | 340,000 | $43,109,000 | 5.59% |
| DAFNA Capital Management LLC | 82,053 | $10,403,000 | 2.71% |
| Ghost Tree Capital, LLC | 60,000 | $7,607,000 | 1.65% |
| CATALYST PRIVATE WEALTH, LLC | 24,976 | $3,167,000 | 1.58% |
| Eventide Asset Management | 748,000 | $94,839,000 | 1.49% |